sr141716 has been researched along with Vomiting in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthenelli, RM; Aubin, HJ; Cinciripini, PM; Dale, LC; Karam-Hage, M; Niaura, R; Robinson, JD | 1 |
| Parker, LA; Rock, EM; Sticht, MA | 1 |
| Bottegoni, G; Limebeer, CL; O'Brien, LD; Parker, LA; Piomelli, D; Rock, EM | 1 |
| Darmani, NA; Griggs, L; Ray, AP | 1 |
| Kwiatkowska, M; Limebeer, CL; Litt, DL; Parker, LA; Piomelli, D; Rock, EM | 1 |
| Breivogel, CS; Crim, JL; Darmani, NA; Janoyan, JJ; Martin, BR; Parekh, B; Sim-Selley, LJ | 1 |
| Crim, JL; Darmani, NA; Janoyan, JJ; Kumar, N | 1 |
| Burton, P; Kwiatkowska, M; Mechoulam, R; Parker, LA | 2 |
| Darmani, NA | 2 |
1 trial(s) available for sr141716 and Vomiting
| Article | Year |
|---|---|
Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation.
Topics: Adult; Anorexia; Anxiety; Cannabinoid Receptor Antagonists; Cigarette Smoking; Diarrhea; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Rimonabant; Smoking Cessation; Vomiting | 2018 |
10 other study(ies) available for sr141716 and Vomiting
| Article | Year |
|---|---|
2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus.
Topics: Animals; Antiemetics; Arachidonic Acids; Cannabinoid Receptor Agonists; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Endocannabinoids; Female; Glycerides; Lithium Chloride; Male; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Shrews; Vomiting | 2013 |
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus).
Topics: Amidohydrolases; Animals; Antiemetics; Arachidonic Acids; Behavior, Animal; Biological Transport; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Isoenzymes; Lithium Chloride; Male; Nausea; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Shrews; Vomiting | 2013 |
Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew.
Topics: Analgesics, Non-Narcotic; Animals; Area Postrema; Brain Stem; Cisplatin; Dronabinol; Drug Therapy, Combination; Female; Immunohistochemistry; Injections, Intraperitoneal; Microscopy, Confocal; Neurons; Oncogene Proteins v-fos; Piperidines; Presynaptic Terminals; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Serotonin; Shrews; Solitary Nucleus; Substance P; Time Factors; Vomiting | 2009 |
The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew).
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Carbamates; Cisplatin; Drug Interactions; Endocannabinoids; Female; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Shrews; Vomiting | 2009 |
Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
Topics: Animals; Antiemetics; Benzoxazines; Binding, Competitive; Brain; Cisplatin; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Shrews; Sulfur Radioisotopes; Tritium; Vomiting | 2003 |
Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.
Topics: Animals; Behavior, Animal; Brain; Dopamine; Dose-Response Relationship, Drug; Female; Male; Piperidines; Pruritus; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Serotonin; Shrews; Vomiting | 2003 |
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Female; Injections, Intraperitoneal; Lithium Chloride; Male; Piperidines; Pyrazoles; Rimonabant; Shrews; Vomiting | 2004 |
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Antineoplastic Agents; Cannabinoids; Cisplatin; Dose-Response Relationship, Drug; Dronabinol; Drug Therapy, Combination; Female; Lithium; Male; Ondansetron; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant; Shrews; Vomiting | 2004 |
Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
Topics: Analgesics, Non-Narcotic; Animals; Cannabinoids; Dronabinol; Female; Male; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Shrews; Vomiting | 2001 |
The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.
Topics: Animals; Antiemetics; Benzoxazines; Cisplatin; Locomotion; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Shrews; Vomiting | 2001 |